Nova Eye Medical (Nova Eye Medical) Forward Dividend Yield % : 0.00% (As of Jun. 17, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Nova Eye Medical Forward Dividend Yield %?

As of today (2024-06-17), the Forward Annual Dividend Yield of Nova Eye Medical is 0.00%.

As of today (2024-06-17), the Trailing Annual Dividend Yield of Nova Eye Medical is 0.00%.

ELXMF's Forward Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.88
* Ranked among companies with meaningful Forward Dividend Yield % only.

Nova Eye Medical's Dividends per Share for the six months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Nova Eye Medical's Forward Dividend Yield %

For the Medical Devices subindustry, Nova Eye Medical's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Eye Medical's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nova Eye Medical's Forward Dividend Yield % falls into.

Nova Eye Medical Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Nova Eye Medical (OTCPK:ELXMF) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Nova Eye Medical Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Nova Eye Medical's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Eye Medical (Nova Eye Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nova Eye Medical Ltd (OTCPK:ELXMF) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

EYE:Australia

Address

107 Rundle Street, Kent Town, Adelaide, SA, AUS, 5067

Website

https://www.nova-eye.com

Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.

Nova Eye Medical (Nova Eye Medical) Headlines

From GuruFocus

Nova Eye Medical Announces U.S. Market Clearance of the iTrack� Advance Canaloplasty Device

By Business Wire Business Wire • 04-12-2023

ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer

By PRNewswire PRNewswire • 07-30-2018